GlassScriptPhysician profile
Christine Ying
NPI 1881091460
$6,494.40
in general payments reported to CMS, 2019-2025
77 companies · $1,885 in 2025
The $1,885 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,170 · 2022: $375 · 2023: $1,868 · 2024: $1,197 · 2025: $1,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,745 · Education: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,744.57 |
| Education | $205.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $644.36 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Emd Serono, INC. | $588.81 | 2021-2023 | Tepmetko |
| Daiichi Sankyo INC. | $515.13 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Novartis Pharmaceuticals Corporation | $463.55 | 2021-2025 | |
| Abbvie INC. | $325.49 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $214.85 | 2021-2025 | Opdivo, Opdualag |
| Eisai INC. | $199.37 | 2021-2025 | |
| Celltrion USA INC. | $168.69 | 2023-2024 | Vegzelma |
| Glaxosmithkline, LLC. | $159.67 | 2023-2025 | Jemperli, Zejula, Ojjaara |
| Regeneron Healthcare Solutions, INC. | $147.22 | 2023-2025 | Libtayo |
| Gilead Sciences, INC. | $146.43 | 2024-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $145.37 | 2021-2025 | |
| Pfizer INC. | $138.36 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $133.85 | 2021-2025 | Enhertu, Calquence |
| Takeda Pharmaceuticals U.S.A., INC. | $132.07 | 2021-2025 | Alunbrig, Ninlaro, Iclusig |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $131.94 | 2021-2025 | Verzenio, Jaypirca |
| Incyte Corporation | $121.09 | 2021-2025 | Jakafi, Zynyz, Pemazyre |
| Sobi, INC | $116.65 | 2024-2025 | |
| Taiho Oncology, INC. | $108.72 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $87.02 | 2023-2025 | Onivyde, Somatuline Depot |
| Janssen Pharmaceuticals, INC | $80.95 | 2021-2024 | Xarelto |
| Dendreon Pharmaceuticals LLC | $77.54 | 2021-2025 | Provenge |
| Seagen INC. | $73.10 | 2021-2023 | Padcev, Adcetris |
| Adc Therapeutics America, INC. | $68.01 | 2023-2025 | |
| Genzyme Corporation | $60.74 | 2021-2024 | |
| Beone Medicines USA, INC. | $53.46 | 2025 | Tevimbra, Brukinsa |
| Rigel Pharmaceuticals, INC. | $52.74 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Genentech USA, INC. | $52.37 | 2023-2025 | Venclexta, Gazyva, Columvi |
| Stemline Therapeutics INC. | $52.15 | 2024-2025 | Orserdu |
| Karyopharm Therapeutics INC. | $50.09 | 2023-2025 | Xpovio |
| Kyowa Kirin, INC. | $49.94 | 2023-2025 | Poteligeo |
| Morphosys, US INC. | $47.30 | 2021-2023 | Monjuvi |
| Celgene Corporation | $46.65 | 2023-2024 | Opdualag, Reblozyl |
| Sun Pharmaceutical Industries INC. | $44.75 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.76 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $40.22 | 2023-2025 | |
| Coherus Oncology, INC. | $39.75 | 2021 | |
| Acrotech Biopharma INC. | $38.91 | 2023 | Beleodaq |
| Beigene USA, INC. | $38.90 | 2024-2025 | Brukinsa |
| Adaptive Biotechnologies Corporation | $38.52 | 2024-2025 | Clonoseq |
| Novocure INC. | $35.29 | 2025 | Optune Gio |
| Iovance Biotherapeutics, INC. | $34.08 | 2025 | Amtagvi |
| Springworks Therapeutics, INC. | $33.54 | 2025 | Ogsiveo, Gomekli |
| Mirati Therapeutics, INC. | $31.86 | 2023-2024 | Krazati |
| Astellas Pharma US INC | $31.82 | 2021-2024 | Padcev |
| Aveo Pharmaceuticals, INC. | $31.58 | 2022-2023 | Fotivda |
| Apellis Pharmaceuticals, INC. | $31.28 | 2022-2024 | Empaveli |
| Pharmacyclics LLC, An Abbvie Company | $30.84 | 2023 | Imbruvica, Epkinly |
| Octapharma USA, INC. | $30.09 | 2022-2025 | Octagam Immune Globulin (Human) |
| Heron Therapeutics, INC. | $24.10 | 2023 | Sustol |
| Tempus Ai, INC | $23.81 | 2024 | Xt Cdx |
| Agios Pharmaceuticals, INC. | $20.79 | 2025 | Pyrukynd |
| Legend Biotech USA INC. | $19.26 | 2025 | Carvykti |
| Azurity Pharmaceuticals, INC. | $19.07 | 2025 | Vivimusta, Danziten |
| Alexion Pharmaceuticals, INC. | $18.78 | 2024 | Ultomiris |
| Invivyd INC | $18.69 | 2025 | Pemgarda |
| Fennec Pharmaceuticals, INC. | $18.65 | 2025 | Fyarro |
| Biocon Biologics INC | $17.80 | 2024 | Ogivri |
| Genmab U.S., INC. | $17.16 | 2023 | Epkinly |
| Geron Corporation | $16.97 | 2025 | Rytelo |
| Syndax Pharmaceuticals, INC. | $16.85 | 2025 | Niktimvo |
| Amgen INC. | $16.76 | 2023 | Lumakras |
| Tersera Therapeutics LLC | $16.46 | 2025 | Zoladex |
| Cumberland Pharmaceuticals, INC. | $15.42 | 2024 | Sancuso |
| Nestle Healthcare Nutrition INC. | $15.29 | 2021 | |
| Kite Pharma, INC. | $15.09 | 2025 | Yescarta |
| Helsinn Therapeutics (U.S.), INC. | $14.99 | 2021 | |
| Csl Behring | $14.79 | 2025 | Privigen |
| Alnylam Pharmaceuticals INC. | $14.75 | 2023 | Givlaari |
| Jazz Pharmaceuticals INC. | $14.73 | 2024 | |
| Amneal Pharmaceuticals LLC | $14.68 | 2025 | Alymsys |
| Blueprint Medicines Corporation | $14.65 | 2023 | Ayvakit |
| Accord Healthcare, INC. | $14.24 | 2023 | |
| Sumitomo Pharma America, INC. | $14.07 | 2023 | Orgovyx |
| Myovant Sciences INC. | $13.85 | 2021 | |
| Foundation Medicine, INC. | $13.70 | 2022 | |
| Janssen Scientific Affairs, LLC | $11.13 | 2023 | Tecvayli |
Drugs and devices associated with these payments
Enhertu $272Venclexta $213Darzalex $213Vegzelma $169Tecvayli $157Libtayo $147Lenvima $141Trodelvy $129Kisqali $126Talvey $109Nubeqa $105Imbruvica $101Epkinly $97.66Inqovi $93.98Lonsurf $93.98Verzenio $93.72Zejula $84.83Jemperli $84.83Jaypirca $77.16Ibrance $75.23Tukysa $75.23Ojjaara $74.84Onivyde $73.80Pluvicto $68.90Xofigo $60.00Piqray $58.63Brukinsa $56.12Optune Gio $54.97Rezlidhia $52.74Tavalisse $52.74Orserdu $52.15Vonjo $51.13Alunbrig $50.96Xpovio $50.09Poteligeo $49.94Erleada $49.73Padcev $49.46Opdualag $48.26Gamifant $47.83Monjuvi $47.40Ninlaro $47.19Injectafer $46.45Scemblix $46.27Fabhalta $42.47Lutathera $39.93Adcetris $39.00Beleodaq $38.91Clonoseq $38.52Carvykti $38.05Tevimbra $36.24Elrexfio $36.00Calquence $35.70Amtagvi $34.08Opdivo $31.98Krazati $31.86Vitrakvi $31.64Stivarga $31.64Provenge $31.27Jakafi $30.48Somatuline Depot $30.32Zynlonta $28.15Orgovyx $27.03Gavreto $26.97Sustol $24.10Xt Cdx $23.81Elitek $22.98Sarclisa $22.98Datroway $21.98Pyrukynd $20.79Tibsovo $20.44Odomzo $20.27Yonsa $20.27Vivimusta $19.07Danziten $19.07Zynyz $19.00Ultomiris $18.78Xarelto $18.69Pemgarda $18.69Fyarro $18.65Ogsiveo $18.63Octagam Immune Globulin (Human) $17.80Ogivri $17.80Synagis $17.69Reblozyl $17.15Bosulif $17.00Empaveli $16.98Emrelis $16.98Rytelo $16.97Tepmetko $16.93Pemazyre $16.89Niktimvo $16.85Elahere $16.76Lumakras $16.76Blenrep $16.70Fotivda $16.69Zoladex $16.46Iclusig $15.67Sancuso $15.42Yescarta $15.09Gomekli $14.91
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Ying listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.